Bioventus BVS
NASDAQ BVS
$13.29 -0.34 (-2.49%)
As of: Sep 10, 2026 · 10:51 AM EDT

Bioventus (BVS) Change in Working Capital (2020 - 2022)

Bioventus' (BVS) quarterly Change in Working Capital came in at $1.1 million in Q2 2022, down 87.62% on a YoY basis from $9.2 million in Q2 2021, and up 59.27% quarter-over-quarter from $712000.0 in Q4 2021.

Analysis

Bioventus (BVS) Change in Working Capital (2020 - 2022) Analysis & Trends

Bioventus (BVS) has reported Change in Working Capital for 3 consecutive years, with $1.1 million the latest figure, recorded in Q2 2022.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Working Cap. (Qtr)
1 Abbott Laboratories 181.92 Bn 176.31 Bn 7.27 Bn -
2 Intuitive Surgical 127.64 Bn 122.42 Bn 1.96 Bn -
3 Medtronic 117.92 Bn 109.10 Bn 6.34 Bn -
4 Stryker 105.39 Bn 101.91 Bn 4.50 Bn -
5 Boston Scientific 64.88 Bn 64.34 Bn 3.85 Bn -
6 Edwards Lifesciences 49.92 Bn 45.66 Bn 1.35 Bn -
7 Alcon 33.24 Bn 31.79 Bn 1.68 Bn -60.00 Mn
8 Dexcom 32.12 Bn 30.18 Bn 830.00 Mn -
9 Steris 20.83 Bn 20.35 Bn 684.20 Mn -
10 Bioventus 902.66 Mn 873.20 Mn 105.67 Mn -
Historic Data

Historic Data

Download Data
DateValue
Apr 2, 2022 1.13 Mn
Oct 2, 2021 712,000.00
Jul 3, 2021 3.85 Mn
Apr 3, 2021 9.16 Mn
Sep 26, 2020 -2.80 Mn
Jun 27, 2020 1.24 Mn
Mar 28, 2020 -369,000.00